FY26 Results: Profit Soars 34%, Special Dividend Declared Amid Income Tax Probe
Akums Drugs and Pharmaceuticals Limited · AKUMS · NSE ·
**Strong Financials**: Consolidated Net Profit for FY26 grew 34% YoY to ₹3,437.77 million. Revenue from Operations increased by 5.85% to ₹43,590.17 million. **Generous Dividend**: The Board recommended a Final Dividend of ₹1.00 and a Special Dividend of ₹2.00, totaling ₹3.00 per…